Cargando…
Rituximab during the COVID-19 pandemic: time to discuss treatment options with patients
Autores principales: | Boekel, L, Wolbink, G J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700274/ https://www.ncbi.nlm.nih.gov/pubmed/34977601 http://dx.doi.org/10.1016/S2665-9913(21)00418-5 |
Ejemplares similares
-
Navigating use of rituximab during the COVID-19 pandemic
por: Elahee, Mehreen, et al.
Publicado: (2023) -
Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic
por: Dougados, Maxime
Publicado: (2021) -
Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population
por: Hooijberg, Femke, et al.
Publicado: (2020) -
Immunity after COVID-19 vaccinations in immunocompromised patients with psoriasis
por: Boekel, Laura
Publicado: (2022) -
Perspective of patients with autoimmune diseases on COVID-19 vaccination
por: Boekel, Laura, et al.
Publicado: (2021)